Ignite Creation Date:
2024-05-06 @ 2:32 PM
Last Modification Date:
2024-10-26 @ 1:32 PM
Study NCT ID:
NCT04340362
Status:
COMPLETED
Last Update Posted:
2023-07-10
First Post:
2020-04-07
Brief Title:
Phase 2a Study of VX-147 in Adults With APOL1-mediated Focal Segmental Glomerulosclerosis
Sponsor:
Vertex Pharmaceuticals Incorporated
Organization:
Vertex Pharmaceuticals Incorporated
Key Dates - Follows AllAPIJSON File Order
Start Date:
2020-06-08
Start Date Type:
ACTUAL
Primary Completion Date:
2021-11-11
Primary Completion Date Type:
ACTUAL
Completion Date:
2021-12-09
Completion Date Type:
ACTUAL
First Submit Date:
2020-04-07
First Submit QC Date:
April 7 2020
Study First Post Date:
2020-04-09
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
2023-07-10
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
2022-11-10
Disp First Submit QC Date:
June 17 2023
Disp First Post Date:
2023-07-10
Disp First Post Date Type:
ACTUAL
Last Update Submit Date:
2023-06-17
Last Update Post Date:
2023-07-10
Last Update Post Date Type:
ACTUAL